Found: 14
Select item for more details and to access through your institution.
Prognostic indices in diffuse large B‐cell lymphoma in the rituximab era: an analysis of the UK National Cancer Research Institute R‐CHOP 14 versus 21 phase 3 trial.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. 1015, doi. 10.1111/bjh.16691
- By:
- Publication type:
- Article
Eradication of minimal residual disease improves overall and progression-free survival in patients with chronic lymphocytic leukaemia, evidence from NCRN CLL207: a phase II trial assessing alemtuzumab consolidation.
- Published in:
- British Journal of Haematology, 2017, v. 176, n. 4, p. 573, doi. 10.1111/bjh.14342
- By:
- Publication type:
- Article
Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R- CHOP) in the management of primary mediastinal B-cell lymphoma: a subgroup analysis of the UK NCRI R- CHOP 14 versus 21 trial.
- Published in:
- British Journal of Haematology, 2016, v. 175, n. 4, p. 668, doi. 10.1111/bjh.14287
- By:
- Publication type:
- Article
A case of Stage IA classical Hodgkin lymphoma with FDG-avid tonsils.
- Published in:
- British Journal of Haematology, 2016, v. 173, n. 2, p. 178, doi. 10.1111/bjh.13953
- By:
- Publication type:
- Article
Guideline on the management of primary resistant and relapsed classical Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2014, v. 164, n. 1, p. 39, doi. 10.1111/bjh.12582
- By:
- Publication type:
- Article
Improvement in Parameters of Hematologic and Immunologic Function and Patient Well-being in the Phase III RESONATE Study of Ibrutinib Versus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Primary results from the double-blind, placebo-controlled, phase 3 SHINE study of ibrutinib in combination with bendamustine-rituximab (BR) and R maintenance as a first-line treatment for older patients with mantle cell lymphoma (MCL).
- Published in:
- Acta Haematologica Polonica, 2022, v. 53, n. A, p. 42
- By:
- Publication type:
- Article
A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2011, v. 152, n. 5, p. 570, doi. 10.1111/j.1365-2141.2010.08317.x
- By:
- Publication type:
- Article
Leukaemia cutis with chronic myelomonocytic leukaemia.
- Published in:
- 2009
- By:
- Publication type:
- Other
Autoimmune neutropenia following therapy for chronic lymphocytic leukaemia: a report of three cases.
- Published in:
- 2007
- By:
- Publication type:
- Letter
Novel translocations that disrupt the platelet-derived growth factor receptor β (PDGFRB) gene in BCR–ABL-negative chronic myeloproliferative disorders.
- Published in:
- British Journal of Haematology, 2003, v. 120, n. 2, p. 251, doi. 10.1046/j.1365-2141.2003.04051.x
- By:
- Publication type:
- Article
Correction of stromal cell defect after bone marrow transplantation in aplastic anaemia.
- Published in:
- British Journal of Haematology, 2001, v. 115, n. 3, p. 642, doi. 10.1046/j.1365-2141.2001.03134.x
- By:
- Publication type:
- Article
Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01142-x
- By:
- Publication type:
- Article
Lymphoid blast crisis after prolonged treatment‐free remission in chronic myeloid leukaemia after tyrosine kinase inhibitor de‐escalation during the COVID‐19 pandemic.
- Published in:
- EJHaem, 2022, v. 3, n. 1, p. 215, doi. 10.1002/jha2.302
- By:
- Publication type:
- Article